BioSpace News Archive

Press Releases

GT Biopharma Advances into Cohort 3 of GTB-3650 Phase 1 Trial Following Safety Review of Cohort 2

August 12, 2025
·
3 min read
Press Releases

BioCryst Announces Departure of Dr. Helen Thackray

August 12, 2025
·
4 min read
Press Releases

Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates

August 12, 2025
·
21 min read
Press Releases

Kraig Biocraft Laboratories to Launch Operations at New Southeast Asia Production Facility This Week

August 12, 2025
·
3 min read
Press Releases

Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025

August 12, 2025
·
2 min read
Press Releases

Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

August 12, 2025
·
1 min read
Press Releases

Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure

August 12, 2025
·
12 min read
Press Releases

KEYTRUDA® (pembrolizumab) plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free and Overall Survival and Pathologic Complete Response Rate for Certain Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery

August 12, 2025
·
19 min read
Press Releases

PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery

August 12, 2025
·
19 min read
Press Releases

Invitation to the Presentation of Cantargia’s H1 2025 Report

August 12, 2025
·
1 min read